Alcon Gross Margin 2019-2022 | ALC
Current and historical gross margin for Alcon (ALC) over the last 10 years. The current gross profit margin for Alcon as of September 30, 2022 is %.
| Alcon Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2022-09-30 |
$8.70B |
$4.78B |
55.02% |
| 2022-06-30 |
$8.66B |
$4.81B |
55.60% |
| 2022-03-31 |
$8.55B |
$4.83B |
56.48% |
| 2021-12-31 |
$8.29B |
$4.65B |
56.11% |
| 2021-09-30 |
$8.08B |
$4.32B |
53.46% |
| 2021-06-30 |
$7.82B |
$3.97B |
50.83% |
| 2021-03-31 |
$6.92B |
$3.10B |
44.77% |
| 2020-12-31 |
$6.83B |
$2.94B |
43.03% |
| 2020-09-30 |
$6.81B |
$2.98B |
43.76% |
| 2020-06-30 |
$6.84B |
$3.08B |
45.06% |
| 2020-03-31 |
$7.53B |
$3.68B |
48.93% |
| 2019-12-31 |
$7.51B |
$3.66B |
48.77% |
| 2019-06-30 |
$5.49B |
$2.37B |
43.12% |
| 2019-03-31 |
$5.41B |
$2.30B |
42.51% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$37.369B |
$8.291B |
|
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
|
